Navigation Links
Arpida Annual General Meeting of Shareholders Approves All Board Proposals
Date:5/7/2008

REINACH, Switzerland, May 7 /PRNewswire-FirstCall/ -- The Annual General Meeting of Arpida Ltd (SWX: ARPN) has approved the proposals that were put forward by the Board of Directors.

A total of 73 shareholders were present at the meeting that took place in Basel today. 6,186,266 shares were represented, or 29.3% of the total number of shares issued (21,094,104).

The following items were on the agenda.

1. Approval of the 2007 Business Report, Company Accounts and Group Accounts

The shareholders approved the 2007 Business Report, comprising the annual financial statements, the consolidated accounts and the 2007 Annual Report.

2. Discharge of the Board of Directors and of the Senior Executive Officers

The shareholders granted discharge to the Board of Directors and to the Senior Executive Officers for their actions.

3. Compensation of Losses with General Reserves

The shareholders approved the Board proposal to compensate the accumulated loss of CHF 27,079,529 with an equal amount of share premium in the general reserves.

4. Elections to the Board of Directors

Elmar Schnee and Dr Khalid Islam were elected for a three year term of office.

Dr Andre Lamotte, Dr Hans Funfschilling and Dr Matthias Staehelin were re-elected for a three-year term of office.

5. Re-election of the Auditors

The shareholders re-elected PricewaterhouseCoopers Ltd as Auditors for 2008.

6. Creation of new Capital which can be used either as Authorised Capital or Conditional Capital (replacement of Article 3ter of the Articles of Association)

The shareholders granted the Board of Directors the authorisation to create total new capital of a maximum of up to CHF 640,000 or 3.2 million Shares, either in the form of authorised or conditional capital.

7. Revision of the Articles of Association concerning Auditors

The shareholders approved the changes to the Articles of Association,
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Leadership Change to Enable Arpida to Become a Fully Integrated Pharmaceutical Company
2. Arpida Announces Conference Call on 17 April
3. Arpida Announces Agenda Items for Shareholders Meeting
4. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
5. Arpida Announces Full Year 2007 Financial Results
6. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
7. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
8. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
9. Arpida-Supported CME Symposium Available Online
10. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
11. Arpida Presents Preclinical Data on AR-2474 at ICAAC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Ambassador to also Visit Detroit , ...avid Appia, French Ambassador for International In...ance Agency, , , , ,What: Ambassador Appia is ava...siness initiatives adopted by France to further de... for innovation and development., , ,When: Availab...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Fir...oday announced that it has received notice from,th...s common stock will be,suspended as of November 30...curities and Exchange Commission, which will remov...less the company files an appeal to the Nasdaq,Lis...
(Date:11/24/2009)...I, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceutical...ice (PTO) has allowed the patent application for,i..., NOD technology is a highly efficient ap...o-adhesive nano-particles to enable oral delivery ... technology is a platform technology,that can be a...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...N.C., Nov. 5 As biopharmaceutical,companies conti... efforts,are placed on strategy and execution from...luations largely focus on revenue growth and littl...launch excellence, a recent study,was conducted by...ith,insights available in the newly published repo...
...-DAC(TM):Exendin-4 Data in December - - PC-Insuli...RNewswire-FirstCall/ - ConjuChem Biotechnologies,I...ete for its Phase II,clinical trial of PC-DAC(TM):...ouble-blind, placebo-controlled, multiple dose stu... months of weekly injections of,PC-DAC(TM):Exendin...
...., Nov. 5 BioMarin,Pharmaceutical Inc. (Nasdaq: ... Chief Executive Officer of BioMarin, will present... Healthcare Conference in Phoenix,Arizona on Wedne...ested parties may access a live audio webcast of t... BioMarin website, http://www.BMRN.com .,A replay...
Other Biology Technology:New Study Provides Key Findings for Biopharma Product Launch Evaluation 2ConjuChem Provides Development Update 2ConjuChem Provides Development Update 3BioMarin to Present at the Credit Suisse Healthcare Conference 2
(Date:11/26/2009)...AMBRIDGE, Mass. (November 26, 2009) Whitehead res...en for human cells to pinpoint specific genes and ...er in Science . , In most human cell cultures g... the father and one from the mother. Gene inactiva...when one copy is inactivated, the second copy usua...
(Date:11/25/2009)...hrelin, a hormone produced in the stomach, may be ...ent of Parkinson,s disease, Yale School of Medicin...ent issue of the Journal of Neuroscience . , Pa...opamine neurons in an area of the midbrain known a...opamine production. Reduced production of dopamin...
(Date:11/25/2009)...ADISON, WI, NOVEMBER 25, 2009 Soil is the linchpi... and hydrosphere meet. Despite that, many students...but nothing more. Soil science educators are chall...blic recognize the critical importance of soil in ...oil science and earth science teachers at Universi...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 1Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 2Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 3UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2Testicular tumors may explain why some diseases are more common in children of older fathers 10512 1Testicular tumors may explain why some diseases are more common in children of older fathers 10512 2
...ffering chronic obstructive pulmonary disease (COP... finding that contradicts the conventional wisdom ... "Evidence for attempted regional elastic fiber re..., Kristin Castillo, Alexander Patterson and Richar... Joel Cooper of the University of Pennsylvania, Ph...
...ring researchers at UC San Diego report in the Nov...changes in a bacterial genome, observed in near-re...y published static "snapshots" of the genome seque...harmless to those that cause plague, but this new ... , "Paleontologists look at the fossil record to s...
...rsity Medical Center have visualized in a living a...to dice and splice genetic material to create uniq...indings, made in mice, help explain a key wonder o... cell of an individual’s body can produce differen...varied proteins, in turn, dictate the function of ...
Other Biology News:Lungs try to repair damaged elastic fibers 2Novel experiment documents evolution of genome in near-real time 2Novel experiment documents evolution of genome in near-real time 3Living view in animals shows how cells decide to make proteins 2Living view in animals shows how cells decide to make proteins 3
Product Information Request - U-0080D Diode Array Bio-Spectrophotometer from Hitachi High Technologies America
...izers are available in two product models - the 50...o models is that the 6000AT+ includes a membrane d...rosol for improved detection limits and reduced ox...limits for a range of elements by 10-40 times. Not...
...5%NEN Radiolabeled Ligands\n\nReceptor-related res...ability of new radiolabeled ligands selected to ke... wide range of products and services for receptor ...ate-of-the-art radioligands. If you do not find ex...
AMV RT HC 600 U from Invitrogen
Biology Products: